Cell-Culture Models of the Blood–Brain Barrier
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
With the increase in average life span, the percentage of patients with neurological diseases is getting higher and higher.1 Thus, developing effective neuropharmaceuticals is critically important and urgent. Sadly, many promising candidates fail to show expected effects because of their inability to cross the blood–brain barrier (BBB), a dynamic interface that separates the central nervous system (CNS) from the circulation system.1 BBB maintains the homeostasis of CNS microenvironment and proper neurological functions by regulating the exchange of substances between the 2 systems.2 Perturbation of BBB has been found in many neurological disorders, including neurodegenerative diseases,3–6 trauma,7,8 brain tumors,9,10 and stroke.11–13 Restoring BBB integrity in pathological conditions to maintain brain homeostasis and opening BBB temporarily to allow efficient delivery of drugs to the CNS are potential therapeutic options for patients with these disorders. For these purposes, a lot of research has focused on the regulation of BBB permeability. Because of the complexity of the in vivo BBB, many simplified in vitro BBB models have been developed and studied, including the monolayer models, coculture models, dynamic models, and microfluidic BBB models. Because no in vitro BBB models can fully replicate the in vivo conditions, there is no perfect in vitro BBB model. Understanding the limitations of these in vitro BBB models would be critical to the design of experiments and interpretation of data. There have been a large number of excellent reviews on in vitro BBB models in the literature. For example, Gumbleton and Audus14 reviewed immortalized cell lines and primary cells used in in vitro BBB models and suggested that an ideal model should have low permeability, possess endothelial-like morphology, express functional transporters, and be easy to …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“In physiological conditions, microglia exist in the brain in the resting state with a ramified morphology.(116) On injury, they quickly change their morphology/gene expression profiles and become activated.”
BackgroundHeart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 1×
“On injury, they quickly change their morphology/gene expression profiles and become activated.(117) Early after injury, microglia take the M1 proinflammatory phenotype, characterized by the secretion of tumor necrosis factor-α and nitric oxide, to prevent the spread of injury.”
BackgroundMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“It has been shown that BMECs express high levels of γ-glutamyl transpeptidase and alkaline phosphatase, which modify many molecules to prevent their entrance into the brain.(74,75)”
BackgroundNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Cited by
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172
“A number of methods may be used to study BBB functions (He et al., 2014).”
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 361
Wevers, N. R., Kasi, D. G., Gray, T., Wilschut, K. J., Smith, B., van Vught, R., Shimizu, F., Sano, Y., Kanda, T., Marsh, G., et al. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0108-3 · Cited by 353
Basement membrane and blood–brain barrier
Xu, L., Nirwane, A., & Yao, Y. (2019) · Stroke and Vascular Neurology · doi:10.1136/svn-2018-000198 · Cited by 352
Self-citationMicrofluidic organ-on-chip technology for blood-brain barrier research
van der Helm, M. W., van der Meer, A. D., Eijkel, J. C. T., van den Berg, A., & Segerink, L. I. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1142493 · Cited by 333
Saunders, N. R., Habgood, M. D., Møllgård, K., & Dziegielewska, K. M. (2016) · F1000Research · doi:10.12688/f1000research.7378.1 · Cited by 143
Alimperti, S., Mirabella, T., Bajaj, V., Polacheck, W., Pirone, D. M., Duffield, J., Eyckmans, J., Assoian, R. K., & Chen, C. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618333114 · Cited by 122
“This may be, in part, because barrier function is widely studied in endothelial monolayers (20, 21) and is also due to the lack of an in vitro system that incorporates both ECs and mural cells, which can be exposed to fluid flow (22).”
BackgroundDing, L., Kshirsagar, P., Agrawal, P., & Murry, D. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060706 · Cited by 62
Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030626 · Cited by 27
Metadata
- Authors
- He, Y., Yao, Y., Tsirka, S. E., & Cao, Y.
- Venue
- Stroke
- Published
- 2014-08
- Volume
- 45
- Issue
- 8
- Pages
- 2514-2526
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2087020733
- Cited by
- 194
- References
- 35
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.